Comprehensive Healthcare Welcomes Addictionologist to Strengthen Substance Use Disorder Care Delivery
YAKIMA, Wash., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Comprehensive Healthcare recently welcomed…
ALKs house dust mite tablet (ACARIZAX) now recommended by NICE for use in the UK health system
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the…
Altair and Cranfield University Sign MoU to Advance Use of Simulation, Data Analytics, and AI
Altair solutions help students and startups pioneer next-generation advancements in aerospace and…
GMT Pay Launches as First Payment Gateway for Everyone to Use Web3 Earnings for Everyday Payments
Sydney, Jan. 22, 2025 (GLOBE NEWSWIRE) -- FSL, the Web3 development studio…
Santhera Receives Positive Recommendation from Scottish Medicines Consortium for the Use of AGAMREE (Vamorolone) in Duchenne Muscular Dystrophy Patients in NHS Scotland
AGAMREE® is approved by MHRA for treating Duchenne muscular dystrophy (DMD) in…
WiSAs CES Partners Highlight WiSA E Software in Diverse Use Cases and Implementations Across the Audio Ecosystem
Innovative audio solutions empower partners to captivate consumers, unlocking fresh revenue streams…
U.S. Food and Drug Administration Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo (nivolumab) Indications1,2
Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given…
Maropost extends its “High Performer” streak in G2 Winter Reports while earning new “Easiest to Use” badge
Marketing Cloud reinforces mid-market excellence in marketing automation across seven categories and…
Monument bank and Quinnox Celebrate Prestigious Win for Best Use of Technology in a Project at 2024 The European Software Testing Awards (TESTA)
Award Recognizes Remarkable Achievements in AI-Powered Testing and Automated Solutions with Monument…
Orca Bio Presents Clinical Results on Use of Orca-Q without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
Orca-Q allogeneic T-cell immunotherapy with no GvHD prophylaxis in patients with matched…